The mechanism of the effects of cilostazol on the symptoms of intermittent claudication is not fully understood. Cilostazol and several of its metabolites are cyclic AMP (cAMP) phosphodiesterase III inhibitors (PDE III inhibitors), inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation, respectively.
Clostazol reversibly inhibits platelet aggregation induced by a variety of stimuli, including thrombin, ADP, collagen, arachidonic acid, epinephrine, and shear stress. Effects on circulating plasma lipids have been examined in patients taking cilostazol. After 12 weeks, as compared to placebo, cilostazol 100 mg b.i.d. produced a reduction in triglycerides of 29.3 mg/dL (15%) and an increase in HDL-cholesterol of 4.0 mg/dL (≡ 10%).
However, please do also talk to a doc/pharmacist, take care, best wishes!
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 19 Mar 2010 • 1 answer
Posted 16 Apr 2010 • 1 answer
Posted 18 Jun 2010 • 1 answer
Posted 7 Aug 2011 • 1 answer
Posted 28 Jul 2013 • 1 answer